NYSE - Delayed Quote USD

Alcon Inc. (ALC)

79.57 -1.19 (-1.47%)
At close: April 24 at 4:00 PM EDT
79.57 +0.03 (+0.04%)
After hours: April 24 at 4:00 PM EDT
Loading Chart for ALC
DELL
  • Previous Close 80.76
  • Open 80.28
  • Bid 79.65 x 900
  • Ask 90.00 x 800
  • Day's Range 79.50 - 80.28
  • 52 Week Range 69.44 - 88.23
  • Volume 851,627
  • Avg. Volume 919,785
  • Market Cap (intraday) 39.896B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 40.60
  • EPS (TTM) 1.96
  • Earnings Date --
  • Forward Dividend & Yield 0.27 (0.34%)
  • Ex-Dividend Date May 10, 2024
  • 1y Target Est 91.70

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

www.alcon.com

25,315

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: ALC

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALC
1.86%
MSCI WORLD
4.78%

1-Year Return

ALC
9.38%
MSCI WORLD
0.00%

3-Year Return

ALC
5.77%
MSCI WORLD
12.71%

5-Year Return

ALC
43.55%
MSCI WORLD
52.72%

Compare To: ALC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALC

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    39.37B

  • Enterprise Value

    43.40B

  • Trailing P/E

    40.60

  • Forward P/E

    25.84

  • PEG Ratio (5yr expected)

    4.45

  • Price/Sales (ttm)

    4.18

  • Price/Book (mrq)

    1.90

  • Enterprise Value/Revenue

    4.59

  • Enterprise Value/EBITDA

    19.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.30%

  • Return on Assets (ttm)

    2.17%

  • Return on Equity (ttm)

    4.83%

  • Revenue (ttm)

    9.45B

  • Net Income Avi to Common (ttm)

    974M

  • Diluted EPS (ttm)

    1.96

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.1B

  • Total Debt/Equity (mrq)

    24.95%

  • Levered Free Cash Flow (ttm)

    416.62M

Research Analysis: ALC

Analyst Price Targets

65.00 Low
91.70 Average
79.57 Current
104.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: ALC

Fair Value

79.57 Current
 

Dividend Score

0 Low
ALC
Sector Avg.
100 High
 

Hiring Score

0 Low
ALC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
ALC
Sector Avg.
100 High
 

Research Reports: ALC

  • Analyst Report: Alcon Inc.

    Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

    Rating
    Price Target
     
  • Economic Growth Amid Slowing Inflation Confounds the Experts

    The Portfolio Selector features the Argus Focus List, a group of 30 "best idea" stocks generated and regularly updated by Argus' analysts and investment policy committee. It also includes the director of research’s monthly investment strategy column, stock recommendations and sector picks, economic forecasts, and an asset allocation model. This month, the Focus List additions are Capital One Financial Corp. (COF); Dominos Pizza Inc (DPZ); Novo Nordisk (NVO); Shell Plc (SHEL) and the Focus List deletions are Alcon Inc. (ALC); Expedia Group Inc (EXPE); Morgan Stanley (MS); Exxon Mobil Corp. (XOM).

     
  • Market Digest: M, NTAP, NYT, BCE, RHHBY, BHF, UBER, ALC, VTRS

    March 4, 2024 Monday Tee Up: Jobs, Powell, COST

     
  • Analyst Report: Alcon Inc.

    Alcon Inc. is a global provider of ophthalmic surgery and vision care products. Founded in 1945 and based in Switzerland, Alcon previously operated as a subsidiary of Novartis AG. It became an independent company on April 9, 2019. The company has more than 25,300 employees.

    Rating
    Price Target
     

People Also Watch